Overexpressing Non-squamous Non-small Cell Lung Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-05
Clinical Trial Update: A Study of BL-M07D1 in Combination With Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic HER2-Overexpressing Non-Squamous NSCLC [Phase 2]
A Phase 2 study evaluating BL-M07D1 in combination with pembrolizumab for unresectable locally advanced or metastatic HER2-overexpressing no…